BR0214753A - 4-feniltetrahidroisoquinolinas, substituìdas, processos para a sua preparação, sua aplicação como medicamento, bem como, medicamento contendo as mesmas - Google Patents
4-feniltetrahidroisoquinolinas, substituìdas, processos para a sua preparação, sua aplicação como medicamento, bem como, medicamento contendo as mesmasInfo
- Publication number
- BR0214753A BR0214753A BR0214753-0A BR0214753A BR0214753A BR 0214753 A BR0214753 A BR 0214753A BR 0214753 A BR0214753 A BR 0214753A BR 0214753 A BR0214753 A BR 0214753A
- Authority
- BR
- Brazil
- Prior art keywords
- medicine
- processes
- preparation
- application
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
"4-FENILTETRAHIDROISOQUINOLINAS, SUBSTITUìDAS, PROCESSOS PARA A SUA PREPARAçãO, SUA APLICAçãO COMO MEDICAMENTO, BEM COMO MEDICAMENTO CONTENDO AS MESMAS". Compostos da fórmula (1), na qual R1 até R9 têm os significados dados nas reivindicações, são acentuadamente adequados com antihipertensivos para diminuir ou impedir estados induzidos isquemicamente, como medicamentos para intervenções cirúrgicas para o tratamento de isquemias do sistema nervoso, do ataque de apoplexia e do edema cerebral, do choque, do estímulo respiratório perturbado, para o tratamento do ronco, como laxante, como agente contra ectoparasitas, para a prevenção contra a formação de cálculos biliares, como antiateroscleróticos, agentes contra complicações tardias do diabetes, doenças de câncer, doenças fibróticas, disfunção endotelial, hipertrofias e hiperplasias de órgãos. Eles são inibidores do trocador de sódio-prótons celular. Eles influenciam as lipoproteínas do soro e podem ser empregados, por conseguinte, para a profilaxia e para a regressão de alterações ateroscleróticas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10159714 | 2001-12-05 | ||
PCT/EP2002/012990 WO2003048129A1 (de) | 2001-12-05 | 2002-11-20 | Substituierte 4-phenyltetrahydroisochinoline, verfahren zu ihrer herstellung, ihre verwendung als medikament, sowie sie enthaltendes medikament |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0214753A true BR0214753A (pt) | 2004-12-14 |
Family
ID=7708117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0214753-0A BR0214753A (pt) | 2001-12-05 | 2002-11-20 | 4-feniltetrahidroisoquinolinas, substituìdas, processos para a sua preparação, sua aplicação como medicamento, bem como, medicamento contendo as mesmas |
Country Status (34)
Country | Link |
---|---|
EP (1) | EP1453810B1 (pt) |
JP (1) | JP4510457B2 (pt) |
KR (1) | KR20050044724A (pt) |
CN (1) | CN100497314C (pt) |
AR (1) | AR037620A1 (pt) |
AT (1) | ATE425968T1 (pt) |
AU (1) | AU2002356689B2 (pt) |
BR (1) | BR0214753A (pt) |
CA (1) | CA2469385A1 (pt) |
CO (1) | CO5580748A2 (pt) |
DE (1) | DE50213372D1 (pt) |
DK (1) | DK1453810T3 (pt) |
EC (1) | ECSP045138A (pt) |
ES (1) | ES2324528T3 (pt) |
HK (1) | HK1072597A1 (pt) |
HR (1) | HRP20040507A2 (pt) |
HU (1) | HUP0600854A2 (pt) |
IL (1) | IL162316A0 (pt) |
MA (1) | MA27147A1 (pt) |
MX (1) | MXPA04005343A (pt) |
MY (1) | MY157371A (pt) |
NO (1) | NO326650B1 (pt) |
NZ (1) | NZ533322A (pt) |
OA (1) | OA12740A (pt) |
PE (1) | PE20030726A1 (pt) |
PL (1) | PL369313A1 (pt) |
PT (1) | PT1453810E (pt) |
RS (1) | RS48004A (pt) |
RU (1) | RU2298003C2 (pt) |
TN (1) | TNSN04100A1 (pt) |
TW (1) | TWI281860B (pt) |
UA (1) | UA77042C2 (pt) |
WO (1) | WO2003048129A1 (pt) |
ZA (1) | ZA200403711B (pt) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10312963A1 (de) * | 2003-03-24 | 2004-10-07 | Aventis Pharma Deutschland Gmbh | Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
TW200526626A (en) | 2003-09-13 | 2005-08-16 | Astrazeneca Ab | Chemical compounds |
DE102004046492A1 (de) * | 2004-09-23 | 2006-03-30 | Sanofi-Aventis Deutschland Gmbh | Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
US20060111393A1 (en) * | 2004-11-22 | 2006-05-25 | Molino Bruce F | 4-Phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
DE102005001411A1 (de) | 2005-01-12 | 2006-07-27 | Sanofi-Aventis Deutschland Gmbh | Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
CA2598423C (en) | 2005-02-18 | 2014-05-27 | Astrazeneca Ab | Antibacterial piperidine derivatives |
JP2008531671A (ja) * | 2005-03-04 | 2008-08-14 | アストラゼネカ アクチボラグ | 化合物 |
DE102005044817A1 (de) * | 2005-09-20 | 2007-03-22 | Sanofi-Aventis Deutschland Gmbh | Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
DE102006012545A1 (de) | 2006-03-18 | 2007-09-27 | Sanofi-Aventis | Substituierte 2-Amino-4-phenyl-dihydrochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
WO2018129556A1 (en) * | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
EP3351248B1 (en) | 2008-12-31 | 2021-06-09 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
US10543207B2 (en) | 2008-12-31 | 2020-01-28 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
ES2446971T3 (es) | 2009-05-12 | 2014-03-11 | Albany Molecular Research, Inc. | Tetrahidroisoquinolinas sustituidas con arilo, heteroarilo, y heterociclo y su uso |
KR102138391B1 (ko) * | 2012-08-21 | 2020-07-27 | 알데릭스, 인코포레이티드 | 체액 저류 또는 염 과부하와 연관된 장애 및 위장관 장애의 치료에서 nhe-매개된 역수송 저해를 위한 화합물 및 방법 |
EP3552630A1 (en) | 2013-04-12 | 2019-10-16 | Ardelyx, Inc. | Nhe3-binding compounds for inhibiting phosphate transport |
CN103788084A (zh) * | 2014-03-02 | 2014-05-14 | 湖南华腾制药有限公司 | 四氢异喹啉衍生物及其合成方法 |
RU2703456C2 (ru) * | 2014-07-25 | 2019-10-17 | Тайсо Фармасьютикал Ко., Лтд. | Фенилтетрагидроизохинолиновое соединение, замещенное гетероарилом |
JP6903923B2 (ja) * | 2016-01-22 | 2021-07-14 | 大正製薬株式会社 | ヘテロアリールで置換されたフェニルテトラヒドロイソキノリン化合物を有効成分として含有する医薬 |
CA3049678A1 (en) * | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Compounds useful for treating gastrointestinal tract disorders |
US11147884B2 (en) | 2017-01-09 | 2021-10-19 | Ardelyx, Inc. | Inhibitors of NHE-mediated antiport |
TWI805137B (zh) * | 2020-12-18 | 2023-06-11 | 大陸商上海濟煜醫藥科技有限公司 | 苯并雜環取代四氫異喹啉類化合物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19951702A1 (de) * | 1999-10-27 | 2001-05-03 | Aventis Pharma Gmbh | Verwendung von 2-Amino-3,4-dihydro-chinazolinen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten |
AU784280B2 (en) * | 1999-11-03 | 2006-03-02 | Albany Molecular Research, Inc. | 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
DE60038185T2 (de) * | 1999-11-03 | 2009-02-19 | Amr Technology, Inc. | Arly- und heteroaryl-substituierte tetrahydroisoquinoline und ihre verwendung als hemmer der wiederaufnahme von norepinephrin, dopamin und serotonin |
EP1113007A1 (en) * | 1999-12-24 | 2001-07-04 | Pfizer Inc. | Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
DE10019062A1 (de) * | 2000-04-18 | 2001-10-25 | Merck Patent Gmbh | 2-Guanidino-4-aryl-chinazoline als NHE-3 Inhibitoren |
-
2002
- 2002-11-20 UA UA20040705310A patent/UA77042C2/uk unknown
- 2002-11-20 AT AT02804183T patent/ATE425968T1/de not_active IP Right Cessation
- 2002-11-20 PL PL02369313A patent/PL369313A1/xx not_active Application Discontinuation
- 2002-11-20 ES ES02804183T patent/ES2324528T3/es not_active Expired - Lifetime
- 2002-11-20 KR KR1020047008697A patent/KR20050044724A/ko active IP Right Grant
- 2002-11-20 NZ NZ533322A patent/NZ533322A/en unknown
- 2002-11-20 CN CNB028278879A patent/CN100497314C/zh not_active Expired - Fee Related
- 2002-11-20 BR BR0214753-0A patent/BR0214753A/pt not_active IP Right Cessation
- 2002-11-20 JP JP2003549321A patent/JP4510457B2/ja not_active Expired - Fee Related
- 2002-11-20 EP EP02804183A patent/EP1453810B1/de not_active Expired - Lifetime
- 2002-11-20 PT PT02804183T patent/PT1453810E/pt unknown
- 2002-11-20 RS YU48004A patent/RS48004A/sr unknown
- 2002-11-20 HU HU0600854A patent/HUP0600854A2/hu unknown
- 2002-11-20 IL IL16231602A patent/IL162316A0/xx unknown
- 2002-11-20 AU AU2002356689A patent/AU2002356689B2/en not_active Ceased
- 2002-11-20 DK DK02804183T patent/DK1453810T3/da active
- 2002-11-20 CA CA002469385A patent/CA2469385A1/en not_active Abandoned
- 2002-11-20 RU RU2004120295/04A patent/RU2298003C2/ru not_active IP Right Cessation
- 2002-11-20 OA OA1200400166A patent/OA12740A/en unknown
- 2002-11-20 DE DE50213372T patent/DE50213372D1/de not_active Expired - Lifetime
- 2002-11-20 MX MXPA04005343A patent/MXPA04005343A/es active IP Right Grant
- 2002-11-20 WO PCT/EP2002/012990 patent/WO2003048129A1/de active Application Filing
- 2002-11-26 PE PE2002001138A patent/PE20030726A1/es not_active Application Discontinuation
- 2002-12-03 TW TW091134977A patent/TWI281860B/zh not_active IP Right Cessation
- 2002-12-03 AR ARP020104667A patent/AR037620A1/es unknown
- 2002-12-04 MY MYPI20024565A patent/MY157371A/en unknown
-
2004
- 2004-05-14 ZA ZA200403711A patent/ZA200403711B/en unknown
- 2004-05-21 MA MA27693A patent/MA27147A1/fr unknown
- 2004-05-25 NO NO20042158A patent/NO326650B1/no not_active IP Right Cessation
- 2004-06-03 CO CO04052088A patent/CO5580748A2/es not_active Application Discontinuation
- 2004-06-04 EC EC2004005138A patent/ECSP045138A/es unknown
- 2004-06-04 HR HR20040507A patent/HRP20040507A2/hr not_active Application Discontinuation
- 2004-06-04 TN TNP2004000100A patent/TNSN04100A1/en unknown
-
2005
- 2005-06-22 HK HK05105174.2A patent/HK1072597A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0214753A (pt) | 4-feniltetrahidroisoquinolinas, substituìdas, processos para a sua preparação, sua aplicação como medicamento, bem como, medicamento contendo as mesmas | |
DE3856442T2 (de) | Verwendung von sulfatierten Zuckern gegen Entzundung | |
BR0112589A (pt) | Derivados de heteroarila e sua aplicação como medicamento | |
DE50211204D1 (de) | Cannabis extrakten pharmazeutische zusammensetzung | |
BR9910801A (pt) | Derivados da pirazolina, a preparação dos mesmose a aplicação dos mesmos como um medicamento | |
BR0113358A (pt) | Derivado de quinazolina ou de um seu sal farmaceuticamente aceitável, processo para a sua preparação, composição farmacêutica, e, uso do derivado ou de um seu sal farmaceuticamente aceitável | |
IS6647A (is) | Kínasólínafleiður til að meðhöndla æxli | |
BR9813373A (pt) | Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente | |
MXPA00009705A (es) | Uso de poliaminas en el tratamiento de sintomas dermatologicos. | |
BR0116605A (pt) | Composto, processo para a preparação de um composto, composição farmacêutica que compreende o mesmo, sua utilização e processo para o tratamento e profilaxia de distúrbios do sistema nervoso central, distúrbios cardiovasculares, distúrbios gastrintestinais e apnéia do sono | |
EP1246629A1 (en) | Methods of using electron active compounds for managing cancer | |
BR9911861A (pt) | Inibidores de farnesil proteìna transferase com as propriedades radiossensibilizadoras in vivo | |
BRPI0111591B8 (pt) | composto, composição farmacêutica, e, usos de um composto | |
BR9914360A (pt) | N-aralquilaminotetralinas como ligandos para oreceptor neuropeptìdeo yy5 | |
EA200801698A1 (ru) | Лекарственные композиции для применения в вагине | |
BRPI0415525A (pt) | derivados de imidazola e seu uso como agentes farmacêuticos | |
BR0016360A (pt) | Derivados de norbornilamino substituìdos, processos para a sua preparação, seu emprego como medicamento ou diagnóstico bem como medicamento contendo os mesmos | |
US20060240119A1 (en) | Pharmacologically active strong acid solutions | |
Hasinoff et al. | The effect of dexrazoxane (ICRF-187) on doxorubicin-and daunorubicin-mediated growth inhibition of Chinese hamster ovary cells | |
DE60105452D1 (de) | Sucralfat enthaltendes arzneimittel zur behandlung von zervikale erosion | |
US3705239A (en) | Pain removing compositions and methods | |
BR0116653A (pt) | Medicamento contendo uma poliamina como substância ativa | |
Zeenat et al. | An appraisal of medicinal properties of Shibb-e-Yamani (Alum): a review | |
PE20030721A1 (es) | Sales de 4-feniltetrahidroisoquinolinio sustituidas, procedimiento para su preparacion, su uso como medicamentos y medicamento que las contiene | |
RU2368609C1 (ru) | Серебряная соль n-(6-метил-2,4-диоксо-1,2,3,4-тетрагидро-5h-пиримидинсульфон)-n'-изоникотиноилгидразида, проявляющая иммунотропную, противомикробную, противогрибковую (противомикотическую) активность, и лекарственное средство на ее основе |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A E 9A ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012. |